TMO
639.56 USD
-2.90%
Today
-3.25%
1D
Market is open
Sun
Closed
Mon
3:00 AM ~ 12:00 PM
Tue
12:00 AM ~ 12:00 PM
Wed
12:00 AM ~ 12:00 PM
Thu
12:00 AM ~ 12:00 PM
Fri
12:00 AM ~ 12:00 PM
Sat
Closed
Information
Name
Thermo Fisher Leveraged
Currency
USD
Standard Leverage
1X
Enhanced Leverage
3X
Overnight Fees Buy
-0.0190%
Overnight Fees Sell
0.0024%
Market Cap
242.11B
Avg Daily Volume
2.04M
52 Week High
683.63 USD
52 Week Low
435.27 USD
Trading Hours
See hours
Overnight Fees Calculator
| Daily Overnight Fee % | Daily Overnight Fee $ | |
|---|---|---|
| BUYS | -0.01900% | $(0.190) |
| SELLS | 0.00240% | $0.024 |
*Results displayed are estimates. Actual fees may differ from those shown as market conditions change.
Business Summary
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services internationally. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The Life Sciences Solutions segment includes reagents, instruments, and consumables for biological and medical research; discovery and production of drugs and vaccines; and diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The Specialty Diagnostics segment offers clinical diagnostics products, such as liquid ready-to-use and lyophilized immunodiagnostic reagent kits, calibrators, controls, protein detection assays, and instruments; immunodiagnostic offerings comprising developing, manufacturing, and marketing of complete blood-test systems for the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; microbiology offerings, such as dehydrated and prepared culture media, collection and transport systems, instrumentation and consumables to detect pathogens in blood, diagnostic and rapid direct specimen tests, quality-control products, and associated products; transplant diagnostics products, including human leukocyte antigen typing and testing for the organ transplant market; and healthcare market channel offerings. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
Top News
ThermoFish
-3.25%
Thermo Fisher Scientific Inc Stock 12‑Month Price Target Raised to $678.17, Implies 2% Upside
tradingview.com
3h ago
ThermoFish
-3.25%
Pharmaceutical CRO Market Forecasts Growth from $45.33B (2025) to $83.31B by 2033, Profiling IQVIA, ICON, Thermo Fisher, Medpace & 5 Other Key Players
finance.yahoo.com
9h ago
ThermoFish
-3.25%
NVIDIA
-0.99%
Apple
+0.84%
Microsoft
+0.25%
Meta
-0.31%
Amazon.com
-0.55%
Alphabet-Class-A
-0.06%
Broadcom
-0.81%
TeslaMotor
-1.17%
AMD.Inc
-2.01%
Amphenol
-1.18%
Lumentum
-3.37%
Hewlett-Packard
-0.71%
PureStorage
+21.15%
Everpure.Inc
+0.31%
PaloAltoNetworks
-0.70%
CrowdStrike
-0.18%
Fortinet
+0.49%
Valero
+3.75%
F5
+0.48%
JohnsonControls
-0.10%
KeysightTech
+0.37%
Waters
-1.01%
The S&P 500 Is Partying at Record Highs: Only 3% of Its Stocks Were Invited
tradingview.com
1d ago
Show more
Frequently Asked Questions
What are healthcare stocks and why are they important to investors?
Healthcare stocks include pharmaceutical companies, biotech firms, hospitals, and medical device manufacturers.
Are healthcare stocks less volatile?
Generally yes. Because healthcare is a necessity, demand remains relatively steady, making the sector less sensitive to economic cycles.
What drives growth in healthcare investments?
Aging populations, technological advancements, and increased healthcare spending contribute to long-term growth in the sector.
What are the risks of investing in healthcare?
Regulatory changes, drug approval delays, and legal challenges can affect the profitability and stock prices of healthcare companies.
